Go to Header
Go to Navigation
Go to Content
Go to Footer
Login
Help
中文(繁體)
Research Resources
CUHK UPDates
Theses
Experts List
User Guides
About Us
List of Researchers
> Clinical Lecturer Ka Yin CHAN
Home
Research Outputs
Researcher Profiles
Department Profiles
Research Areas
Professor CHAN Ka Yin
Personal Information
ORCiD
0000-0001-9176-963X
ResearcherID
I-2535-2015
CUHK Research Outputs
1 of 2
scONE-seq: A single-cell multi-omics method enables simultaneous dissection of phenotype and genotype heterogeneity from frozen tumors
(
2023
)
The E2F1–HOXB9/PBX2–CDK6 axis drives gastric tumorigenesis and serves as a therapeutic target in gastric cancer
(
2023
)
Combinations of Single-Gene Biomarkers Can Precisely Stratify 1,028 Adult Gliomas for Prognostication
(
2022
)
Establishment and characterization of meningioma patient-derived organoid
(
2021
)
Low-grade BRAF V600E mutant oligodendroglioma-like tumors of children may show EGFR and MET amplification
(
2021
)
Mismatch repair proteins PMS2 and MLH1 can further refine molecular stratification of IDH-mutant lower grade astrocytomas
(
2021
)
Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas
(
2021
)
Clinical and mutational profiles of adult medulloblastoma groups
(
2020
)
IDH mutant lower grade (WHO Grades II/III) astrocytomas can be stratified for risk by CDKN2A, CDK4 and PDGFRA copy number alterations
(
2020
)
Patient-derived tumor organoid predicts drugs response in glioblastoma: A step forward in personalized cancer therapy?
(
2020
)
Identification of subsets of IDH-mutant glioblastomas with distinct epigenetic and copy number alterations and stratified clinical risks
(
2019
)
Blended Learning in Anatomy Teaching for Non-Medical Students: An Innovative Approach to the Health Professions Education
(
2018
)
Oligodendrogliomas in pediatric and teenage patients only rarely exhibit molecular markers and patients have excellent survivals
(
2018
)
Pediatric low-grade gliomas can be molecularly stratified for risk
(
2018
)
Specific targeting of point mutations in EGFR L858R-positive lung cancer by CRISPR/Cas9
(
2018
)
SRGAP1, a crucial target of miR-340 and miR-124, functions as a potential oncogene in gastric tumorigenesis
(
2018
)
Adult IDH wild-type lower-grade gliomas should be further stratified
(
2017
)
Adult IDH wild-type lower-grade gliomas should be further stratified
(
2017
)
Glioma groups classified by IDH and TERT promoter mutations remain stable among primary and recurrent gliomas
(
2017
)
TERT promoter mutation and its interaction with IDH mutations in glioma: Combined TERT promoter and IDH mutations stratifies lower-grade glioma into distinct survival subgroups-A meta-analysis of aggregate data
(
2017
)
The kinesin KIF14 is overexpressed in medulloblastoma and downregulation of KIF14 suppressed tumor proliferation and induced apoptosis
(
2017
)
Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas
(
2017
)
Aberrantly expressed microRNA in BRAF mutated young adult GBM
(
2016
)
ABERRANTLY EXPRESSED microRNAs IN BRAF MUTATED YOUNG ADULT GBM
(
2016
)
Biomarker-based prognostic stratification of young adult glioblastoma
(
2016
)
HG-07 Aberrantly Expressed microRNAs in BRAF Mutated Young Adult GBM
(
2016
)
IDH alone does not supersede histologic grading in lower grade gliomas
(
2016
)
Inferior outcome and poor response to conventional therapies in pediatric low-grade gliomas harboring the BRAF V600E mutation
(
2016
)
Malignant transformation of pilocytic astrocytoma to glioblastoma
(
2016
)
Not all 1p/19q non-codeleted oligodendroglial-like tumors are astrocytic
(
2016
)
Not all 1p/19q non-codeleted oligodendroglial tumors are astrocytic
(
2016
)
Pediatric oligodendroglioma patients exhibit large differences with their adult counterparts: excellent survival and rarely detected molecular markers
(
2016
)
TP53 and Histone H3.3 Mutations in Triple-Negative Lower-Grade Gliomas
(
2016
)
Combination genetic signature stratifies lower-grade gliomas better than histological grade
(
2015
)
ESTABLISHING THE ROLE OF ARGININE DEPRIVATION WITH THE RECOMBINANT HUMAN ARGINASE PEG-BCT-100 IN THE TREATMENT OF ADULT GLIOMAS
(
2015
)
H3F3A, IDH1 and BRAF mutations define clinical subgroups of young adult GBM
(
2015
)
Molecular markers in 1p/19q intact oligodendroglial tumors
(
2015
)
MPTH-24. COMBINATION GENETIC SIGNATURE STRATIFIESPROGNOSIS IN LOWER-GRADE GLIOMAS BUT IDH STATUSALONE DOES NOT SUPERSEDE HISTOLOGIC GRADES
(
2015
)
Preclinical Evaluation of Recombinant Human Arginase PEG-BCT-100 leading to Arginine Deprivation in Gliomas
(
2015
)
TERT promoter mutated WHO grades II and III gliomas are located preferentially in the frontal lobe and avoid the midline
(
2015
)
TERT promoter mutations contribute to IDH mutations in predicting differential responses to adjuvant therapies in WHO grade II and III diffuse gliomas
(
2015
)
TERT promoter mutations contribute to subset prognostication of lower-grade gliomas
(
2015
)
TERT promoter mutations contribute to subset prognostication of lower-grade gliomas
(
2015
)
Loss of CIC and FUBP1 expressions are potential markers of shorter time to recurrence in oligodendroglial tumors
(
2014
)
Loss of CIC and FUBP1 expressions are potential markers of shorter time to recurrence in oligodendroglial tumors
(
2014
)
Surgically treated incidentally discovered low-grade gliomas are mostly IDH mutated and 1p19q co-deleted with favorable prognosis
(
2014
)
TERT promoter mutations contribute to subset prognostication of lower grade gliomas
(
2014
)
WHO’s Next? A Molecular Classification of Lower Grade Gliomas
(
2014
)
MIR-137 Suppresses Growth and Invasion, is Downregulated in Oligodendroglial Tumors and Targets CSE1L
(
2013
)
Mutation Analysis of IDH1 in Paired Gliomas Revealed IDH1 Mutation Was Not Associated with Malignant Progression but Predicted Longer Survival
(
2013
)
Share Link
Last updated on 2023-05-04 at 06:39
Share Link
Your name*
Your email*
Recipient's name*
Recipient's email*
Message
Auxilliary Information
No information will be stored or shared with any third party.
Cancel
Our policy towards the use of cookies
All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Ok to Continue
Cookie Policy